Robert Chu and Richie Etwaru tell Craig Sharp that pharma has to orchestrate a truly integrated effort from sales and marketing teams to attain commercial effectiveness.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS